explore -WSS

explore

author：focus 2025-10-02 18:48:30 - browse：245

This is the online edition of Adam’s Biotech Scorecard, a subscriber-only newsletter. STAT+ subscribers can sign up here to get it delivered every Thursday to their inbox.

I have one more, admittedly braggy thing to say about last week’s STAT Breakthrough Summit West in San Francisco. Of course we curated an incredible roster of influential industry leaders to speak on stage. That’s what STAT does. But just as remarkable were the health care and health tech A-Listers who just showed up as summit attendees to listen and learn from their peers — like 23AndMe’s Anne Wojcicki. Please join us in San Francisco next year, or better yet, register for our next summit in Boston, Oct. 16-17.

I’m back in Boston from San Francisco, but flying out again next week, this time to Chicago for the annual meeting of the American Society of Clinical Oncology. How can we be knocking on June, already?

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Novavax promises a turnaround & Lilly roils the obesity market
Next article： Harvard's David Sinclair gets blowback over aging

focus

WSS

Think you might have Covid

The untold story of TV’s first prescription drug ad

The untold story of TV’s first prescription drug ad

Longer MASH drug regimen improved liver, Akero study finds

Think you might have Covid

Florida health officials providing scant details on measles cases

focus

explore

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

hotspot

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Gilead’s Trodelvy fails in lung cancer, raises questions on ADCs

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Ancient Greek ideas underpin modern concepts of pregnancy

Medicare proposal to cover medical devices draws a mixed reaction

State of the Union pitch: Bigger Medicare drug price negotiations

George Santos makes 1st court appearance after pleading not guilty to 13 counts

The public health thinking behind the CDC’s new Covid guidance

State Dept. review finds Biden bears some blame for Afghanistan failures

Medicare drug price negotiation hearing pits pharma v Biden admin

entertainment

Why doctors need education on FDA device approval process

Readout Newsletter: BridgeBio, Madrigal, and Silicon Valley Bank

Pregnant women don't need prenatal multivitamins, study concludes

Harvard's David Sinclair gets blowback over aging

The surgeon had a dilemma only a Nazi medical text could resolve

NIH director takes cautious approach to Biden drug pricing priority

focus

knowledge

leisure time

Wikipedia